Previous studies suggested that RGS2, RGS4 and RGS5 were protective against airway-hyperresponsiveness with modulated airway or bronchial contractility [4,5,6], while RGS2 was protective against bleomycin-induced lung fibrosis [7]. The gene discussed is RGS2; the disease is pulmonary fibrosis.